Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CVS Health : Research Institute Study Shows 11.4 Percentage Point Improvement in Medication Adherence Among Patients in Specialty Connect Pilot

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/10/2016 | 04:13am CET

WOONSOCKET, R.I., Jan. 29, 2016/PRNewswire/ --New research published by the CVS Health (NYSE: CVS) Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health's innovative specialty prescription services program. New patients enrolled in the pilot were 17.5 percent more likely to pick up their first refill and existing specialty patients had an 11.4 percentage point improvement in adherence, as compared to a control group. The study was published in the most recent issue of the Journal of the American Pharmacists Association.

'The specialty market is growing rapidly and new high-cost specialty drugs, that were once limited to small patient populations, are now increasingly being indicated to treat many more patients,' said William Shrank, M.D., chief scientific officer and senior vice president, CVS Health. 'As new specialty medications are introduced, adherence to therapy will be particularly important to optimize the benefit of these very expensive medications. Specialty Connect, combined with evidence-based benefit design and utilization management strategies, can increase the likelihood that the most appropriate patients receive specialty medications and that, once received, they take them as prescribed.'

CVS Health piloted the Specialty Connect program in 115 CVS Pharmacy stores before launching the program nationwide. Patients enrolled in the pilot could choose to have medications delivered to their home or doctor's office or opt to pick up their specialty medications at their local CVS Pharmacy, while receiving specialized clinical support from CVS Specialty, the specialty pharmacy of CVS Health. Since the program's launch, more than 100,000 patients have been served, with more than half choosing to pick up their specialty prescriptions at retail.

Specialty medicines treat complex conditions such as rheumatoid arthritis, multiple sclerosis and hepatitis C. Many of these medications require special handling, storage and administration. In addition, many specialty drugs are only available at select specialty pharmacies to help ensure compliance with required safety and compliance protocols. As a result, patients often have difficulty with the logistics of filling a new prescription for a specialty medication, with as many as one quarter of traditional retail pharmacies unable to fill a specialty prescription without barriers and/or delays. CVS Specialty is the only specialty pharmacy that offers patients a choice of where to get their medicines, either at any CVS Pharmacy location or through mail delivery, which simplifies getting started on a specialty therapy. In addition, the Specialty Care Team provides round-the-clock support and patient care, including symptom management, claims processing and help managing comorbid conditions.

'CVS Specialty is the only specialty pharmacy that integrates rare disease management and coordinated care programs to make it easier for patients to start and stay on complex treatments,' added Alan Lotvin, M.D., president, CVS Specialty and executive vice president, CVS Health. 'Since we launched Specialty Connect across all CVS Pharmacy locations, we have seen high rates of adherence, and our specialty patients have reported extremely high satisfaction with their service.'

The CVS Health Research Institute is focused on contributing to the body of scientific knowledge related to pharmacy and health care through research collaborations with external academic institutions, participation in federally-funded research, analysis and sharing of CVS Health data sources and coordination of pilot programs and initiatives. CVS Health Research Institute findings support a continuous quality improvement environment, which encourages product innovation and development to benefit CVS Health patients, clients and their members.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health atwww.cvshealth.com.

Logo- http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health

CVS Health Corporation issued this content on 29 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 10 February 2016 03:12:28 UTC

Original Document: http://www.cvshealth.com/content/cvs-health-research-institute-study-shows-114-percentage-point-improvement-medication

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
11/21 CVS PHARMACY : 's Exclusive Black Friday and Cyber Monday promotions help custom..
11/20 REPORT : Buyout of Aetna Inc. Could Come This Month
11/20DJCVS HEALTH : Takeovers Roar to Life as Companies Hear Footsteps From Tech Giants
11/20 SUPPORTING BETTER HEALTH ACROSS THE : CVS Health Impact Dashboard
11/16 CVS HEALTH : Makes Overdose-Reversal Drug Available Without Individual Prescript..
11/16 CVS HEALTH : Earns Perfect Score in 2018 Corporate Equality Index
11/16 CVS HEALTH : Surescripts Transforms Prescription Decision Process Between Physic..
11/15 CVS HEALTH : delivering next-day service come the new year
11/15 Bayer hires new blood to stem 'Amazon effect' in consumer health
11/15 CVS HEALTH : Delaware, CVS Health make overdose reversal drug available without ..
More news
News from SeekingAlpha
11/23 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2017 Updat..
11/22 Sorry, Indexing Is Not The Problem
11/22 Mystery Stocks Revealed In My 88 Stock Portfolio Along With 2018 Income Estim..
11/22 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q3 2017 Upda..
11/21 NEW DIV ON THE BLOCK QUARTERLY EARNI : Part 2
Financials ($)
Sales 2017 184 B
EBIT 2017 9 954 M
Net income 2017 5 242 M
Debt 2017 24 377 M
Yield 2017 2,73%
P/E ratio 2017 14,24
P/E ratio 2018 12,32
EV / Sales 2017 0,53x
EV / Sales 2018 0,50x
Capitalization 72 409 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 84,5 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-9.39%72 409
WALGREENS BOOTS ALLIANCE-14.02%72 011
EXPRESS SCRIPTS HOLDING CO-9.70%35 183
MCKESSON CORPORATION1.72%30 396
CARDINAL HEALTH INC-22.58%17 958
AMERISOURCEBERGEN CORP.1.62%17 752